marketinsider

“Reflecting on Immutep’s Q2 FY25: A Quarter Filled with Progress and Promise”

Media Release for Immutep’s Transition to Phase III Biotech TACTI-004 Trial in Non-Small Cell Lung Cancer Receives Regulatory Approval It is with great excitement that Immutep announces its transition to a Phase III biotech company. This milestone has been marked by the regulatory approval of the pivotal TACTI-004 trial in first-line non-small cell lung cancer…

Read More

“Breaking News: Bitcoin Hits Record High of $104K on Jan 31st, 2025 – Jasmy Coin Skyrockets by 25%!”

Cryptocurrency Market Update: Minor Correction Amidst Continued Optimism Market Analysis The cryptocurrency market today has experienced a slight setback, with the total market cap decreasing by 1.8% to $3.69 trillion. Despite this dip, trading activity remains robust, with the 24-hour volume reaching $116.99 billion. The Fear & Greed Index is currently at 76, indicating a…

Read More

“Attention Shareholders: Revance Therapeutics Inc. Faces Class Action Lawsuit – Find Out More from Johnson Fistel Law Firm!”

Welcome to the Johnson Fistel, LLP Lawsuit Party! Revance Therapeutics, Inc. Investors – Get in Here! Hey there all you savvy investors of Revance Therapeutics, Inc. (NASDAQ:RVNC)! Have you heard the news? Johnson Fistel, LLP is throwing a class action lawsuit party in your honor! That’s right, folks! If you acquired securities between February 29,…

Read More

“Revving Up for the Future: Revvity’s 2025 Revenue and Profit Fall Below Expectations Due to Decline in Biotech Spending”

Medical equipment maker Revvity forecasts below estimates for 2025 Introduction On Friday, Revvity, a leading medical equipment maker, announced their full-year profit and revenue forecast for 2025, which fell below Wall Street estimates. The company cited soft demand for their products and services used in drug research as the reason for the lower-than-expected projections. The…

Read More

“Orogen Royalties Announces Annual Equity Compensation Grant for Metals and Mining Industry”

Orogen Royalties Inc. Announces Grant of Share-Based Compensation Vancouver, BC / ACCESS Newswire / January 31, 2025 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. (“Orogen” or the “Company”) has recently announced the authorization of a grant of share-based compensation as part of its annual program. The Board of Directors have approved the issuance of 324,000 Restricted Share…

Read More

“Goodbye to a Great: First Horizon Bids Farewell to Director Harry V. Barton Jr.”

First Horizon Corporation Announces Retirement of Harry V. MEMPHIS, Tenn., Jan. 31, 2025 /PRNewswire/ — First Horizon Corporation (NYSE: FHN or “First Horizon”) announced today the retirement of Harry V. In a surprising move, First Horizon Corporation has announced the retirement of long-time employee Harry V. While details surrounding his retirement are not fully disclosed,…

Read More